Previous Article | Next Article 
Journal of Virology, August 2001, p. 7107-7113, Vol. 75, No. 15
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.15.7107-7113.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Phage Display of Adenovirus Type 5 Fiber Knob as a
Tool for Specific Ligand Selection and Validation
Alexander
Pereboev,
Larisa
Pereboeva, and
David T.
Curiel*
Division of Human Gene Therapy, Department of
Medicine, Surgery and Pathology, Gene Therapy Center, University of
Alabama at Birmingham, Birmingham, Alabama
Received 11 January 2001/Accepted 16 April 2001
 |
ABSTRACT |
Adenovirus (Ad) vectors are most potent for use as gene delivery
vehicles to infect human cells in vitro and in vivo with high
efficiency. The main limitation in utilization of Ad as a gene transfer
vector is the lack of specificity. Genetic modifications of Ad capsid
proteins resulting in incorporation of foreign polypeptide ligand
sequences can redirect the vector towards target cells. However, in
many cases the incorporated ligands lose specificity or lead to
conformational changes influencing virion integrity. In order to select
target-specific ligands a priori structurally compatible with Ad, we
propose a system for displaying polypeptide sequences in the context of
the Ad fiber knob on the surfaces of filamentous bacteriophages. To
establish this concept, we displayed the wild-type Ad serotype 5 knob
and knobs containing c-Myc epitopes and six-histidine sequences in the
pJuFo phage system. The knobs remained trimeric and bound the
coxsackievirus-Ad receptor, and the phage knob-displayed ligands
recognized and bound their cognates in the phage-displayed knob
context. Further development of this system may be useful for candidate
ligand fidelity and Ad structural compatibility validation prior to Ad modification.
 |
INTRODUCTION |
Adenovirus serotype 5 (Ad5) is the
most commonly used vector for gene therapy because it demonstrates an
outstanding efficacy of gene transfer in vivo; it infects both
proliferating and highly differentiated cells. Ad5 grows to high titer,
and large (up to 6.5-kb) foreign DNA fragments can be incorporated into
the Ad genome serving as a transgene. However, Ad as a gene therapy
vector also has disadvantages, including the broad distribution of the Ad primary receptor
the coxsackievirus-Ad receptor (CAR)
which precludes specific gene delivery. In addition, many malignant cell
types lack the CAR and are therefore not permissive for gene therapy
with nontargeted Ad vectors (for a review, see reference 18). Ad retargeting, that is, redirecting the viral
infection to certain cells specifically, is therefore one of the major
areas being addressed by many investigators in the field
(3).
A number of strategies have been developed to achieve targeted gene
delivery with Ad vectors. Two general approaches are currently used to
modify the natural tropism of Ad. One approach in Ad targeting is to
use bispecific molecular "bridges" (chemical or genetic fusion
conjugates), one end of which specifically binds a virus capsid protein
whereas the other end binds to a cellular marker (5, 6, 8, 9, 15,
21). The other approach is genetic modification of the virus
particle itself, thereby incorporating specific targeting ligands
directly into Ad capsid proteins, which in turn permits Ad to acquire
expanded tropism. Since the Ad fiber protein, and its carboxy-terminal
knob domain in particular, plays the major role in virus-cell
interaction (12), this protein is a reasonable site for
specific ligand incorporation. Two distinct locales within the Ad knob
domain have been employed to modify viral tropism: the carboxy terminus
(13, 22) and the HI loop of the fiber knob (4, 10,
23). A critical consideration in generation of Ads with modified
knobs is the need for the knob fiber to retain its natural ability to
form trimers. Therefore, knob-ligand structural compatibility is one of
the key issues to be addressed while creating genetically modified Ad
vectors. In addition, promising candidate ligands very often lose their fidelity as targeting moieties once they are introduced into the Ad
virion. Thus, the two issues of ligand structural compatibility and
"in-context" fidelity are critical.
A promising way to identify potential targeting moieties is to exploit
a high-throughput approach, such as screening of phage-displayed ligand
libraries. However, considering the above-mentioned issues, for
development of new targeted Ad vectors it would be desirable to improve
such an approach by combining the advantage of high-throughput phage
library screening with in-context ligand functional and structural
suitability. This could be achieved by screening ligand libraries
incorporated directly into the Ad5 knob domain displayed on the
surfaces of bacteriophages. However, the conventional filamentous-phage display allows only amino-terminal insertions into the product of gene
III (20), whereas the Ad knob is the C-terminal portion of
the fiber. To circumvent this obstacle, we decided to employ a phage
display system, pJuFo (2), which was originally designed to display C-terminal protein fragments. This system explores a strong
association of the Jun and Fos leucine zipper domains. The vector
features simultaneous production of two recombinant proteins: phage
protein pIII fused with the Jun polypeptide and the cDNA product fused
with Fos. Both proteins are transported into the periplasm, where the
Jun-Fos association occurs followed by stabilization of the heterodimer
by two disulfide bonds (Fig. 1A). The
recombinant pIII carrying a covalently attached cDNA product is then
incorporated into the phage body, and thus, the product becomes phage
displayed (Fig. 1B). Wild-type pIII is provided in trans by
a helper phage and is necessary for phage infectivity. Theoretically,
phagemid-based systems allow up to five copies of recombinant protein
to be displayed on one phage particle. Our hypothesis was that
neighboring knobs would form trimers on the phage surface and such
phage-displayed trimeric knobs would therefore represent a tool for
studying potential ligand structural compatibility and fidelity (Fig.
1C). In the present proof-of-principle study, we describe phage display
of functional Ad5 knobs in the pJuFo system and address the issues of
ligand-knob fidelity and ligand-knob compatibility.

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 1.
Display of the Ad5 knob on the surface of filamentous
bacteriophage. For a detailed explanation, see the text.
|
|
 |
MATERIALS AND METHODS |
Phage display.
The pJuFo phagemid vector was obtained from
Reto Crameri (Swiss Institute of Allergy and Asthma Research, Davos,
Switzerland). The bacterial host for cloning and phage propagation was
Escherichia coli XL1 Blue (Stratagene, La Jolla, Calif.).
The helper phage was VCSM13 (Stratagene).
Cloning and phage display of Ad fiber knobs.
General
microbiological and molecular biological techniques and recipes for
bacterial growth media are described in reference (19).
The wild-type Ad5 fiber knob gene fragment coding for amino acid
positions 386 to 581 of the fiber (according to reference 1), including the last fiber shaft repeat and the entire
Ad5 knob, was PCR amplified from the plasmid pNEB.PK3.6
(11) using the primers Xba_knob_for (5'-ATA TCT
AGA ACA GGT GCC ATT ACA GTA GGA A-3') and knob_Kpn_rev
(5'-AAC GGT ACC TTA TTC TTG GGC AAT GTA TGA A-3').
The XbaI and KpnI restriction sites
(underlined) were introduced into the amplification product. The PCR
product was digested with XbaI/KpnI and cloned
into the pJuFo vector also cut with XbaI/KpnI.
This resulted in phagemid pJuFo.w.t.kn.
The knob containing six consecutive histidine residues (sixHis) at the
carboxy terminus of the fiber open reading frame was
amplified from the
plasmid pBS.F5.RGS6HSL (
7) using the primers
Xba_knob_for
(see above) and F5.R+17 (5'-TTG AAA AAT AAA CAC GTT
GA AAC-3').
The PCR product contained the
KpnI restriction site
from the parent plasmid. The fragment was cloned into the pJuFo
vector
as described above. This resulted in phagemid pJuFo.kn.6H(C).
To introduce the c-Myc epitope into the C terminus of the Ad5 knob, two
oligonucleotides, C_knob_myc (5'-GAT CCG AAC AAA AGC
TGA TCT CAG
AAG AAG ATC TAG-3') and C_knob_myc_r (5'-GAT CCT AGA
TCT TCT
TCT GAG ATC AGC TTT TGT TCG-3'), were annealed, and the
duplex
was ligated to the pBS.F5.RGS6HSL plasmid digested with
BamHI, thus replacing the fragment coding for sixHis with
the
c-Myc sequence. This resulted in plasmid pBS.F5.RGSMycSL. From
this
plasmid, the c-Myc-containing Ad5 knob gene fragment was
amplified and
cloned into pJuFo as described for the six-His knob
(above). This
resulted in phagemid pJuFo.kn.myc(C).
In order to facilitate cloning into the HI loop, an intermediate
vector, pJuFo.kn.2Esp, was constructed, allowing peptide
insertions
without disruption of the native Ad5 knob amino acid
composition (Fig.
2). Twelve base pairs coding for a
Gly(543)-Asp-Thr-Thr(546)
oligopeptide were deleted, and two adjacent
Esp3I restriction
sites were introduced into the opposite
DNA strands of the knob
gene. Two portions of the knob gene were PCR
amplified from pJuFo.w.t.kn
and connected by blunt-end ligation. The
forward primer for the
"left" PCR fragment (Fig.
2) was SEQpJuFo_F
(5'-AAG AAA AGC TGG
AGT TCA TC-3'), and the reverse primer
for the "right" PCR fragment
was SEQpJuFo_R (5'-ACG ACG GCC
AGT GAA TTG TA-3') (these primers
were also used for DNA
sequencing of knob-pJuFo derivatives).
The reverse primer for the
"left" fragment was designed to substitute
the triplet GAA coding
for Glu(541) for GAG and the triplet ACA
coding for Thr(542) for ACG,
thus introducing an
Esp3I restriction
site into the
complementary DNA chain (primer pJuFo_Esp_r
[5'-CGTCTCCTGTGTACCGTTTAGTGTAATG-3']).
The forward primer
for the "right" fragment was designed to introduce
another
Esp3I site into the plus-DNA chain and to substitute the
triplet CCA coding for Pro(547) for CCT, which allowed formation
of an
AvrII-compatible cohesive end after the phagemid was cleaved
with
Esp3I (primer pJuFo_Esp_f [5'-CGT CTC CCT AGT GCA
TAC TCT
ATG TCA TTT TCA-3']).

View larger version (42K):
[in this window]
[in a new window]
|
FIG. 2.
Construction of pJuFo.kn.2Esp vector for unidirectional
cloning within the Ad5 knob HI loop. (A). The vector was designed to
allow peptide insertions without disruption of the native Ad5 knob
amino acid composition. Twelve base pairs coding for a
Gly(543)-Asp-Thr-Thr(546) oligopeptide were deleted, and two adjacent
Esp3I restriction sites were introduced into the opposite
DNA strands of the knob gene. Two portions of the knob gene were PCR
amplified from pJuFo.w.t.kn and connected by blunt-end ligation. The
reverse primer for the left fragment was designed to substitute the
triplet GAA coding for Glu(541) for GAG and the triplet ACA coding for
Thr(542) for ACG, thus introducing an Esp3I restriction site
into the complementary DNA chain. The forward primer for the right
fragment was designed to introduce another Esp3I site into
the plus-DNA chain and to substitute the triplet CCA coding for
Pro(547) for CCT, which allowed the formation of an
AvrII-compatible cohesive end after the phagemid was cleaved
with Esp3I. (B) Cloning of the c-Myc epitope into the HI
loop of the Ad5 knob displayed on phage. The stuffer sequence is
removed by Esp3I digestion and replaced with an
oligonucleotide duplex.
|
|
To incorporate the c-Myc epitope into the HI loop, a pair of
oligonucleotides, myc_in_HIknob (5'-TAT ACA CAG
GAG
ACG GGA GAC
ACA ACT GAA CAA AAG CTG ATC TCA GAA GAA GAT CTA
CCT AGG ATG C-3')
and myc_in_HIknob_r (5'-GCA
T
CC TAG GTA GAT CTT CTT CTG AGA TCA
GCT TTT GTT CAG TTG TGT
CTC C
CG TCT CCT GTG TAT A-3'), were annealed
and
digested with
Esp3I and
AvrII (underlined), and
the digestion
product was cloned into pJuFo.kn.2Esp cleaved with
Esp3I. This
resulted in phagemid pJuFo.kn.myc(HI).
The correct nucleotide compositions of all cloning intermediates and
the final pJuFo phagemids containing modified Ad5 knobs
were confirmed
by DNA sequencing using a CEQ2000 automatic sequencer
and a CEQ dye
terminator sequencing kit from Beckman Coulter (Fullerton,
Calif.).
The phagemids pJuFo, pJuFo.w.t.kn, pJuFo.kn.6H(C), pJuFo.kn.myc(C), and
pJuFo.kn.myc(HI) were used to transform
E. coli XL1
Blue
bacteria for phagemid DNA propagation and recombinant-phage
production.
Phage rescue was done by coinfection of mid-log-phase
bacterial culture
with the helper phage VCSM13 at the phage-to-bacteria
ratio of 20:1,
followed by overnight cultivation at 37°C and double
polyethylene
glycol precipitation (
2). The phage titer was
determined
by a colony-forming assay as described previously (
19).
Immunological methods.
Phage yield, the presence of trimeric
knobs, and the solvent accessibility of knob-displayed ligands were
assayed by dot blot analysis of phage displaying either the wild-type
(wt) knob or ligand-containing knobs. The parent pJuFo phage displaying
no knob was used as a negative control. One-microliter aliquots of the
phage were applied to nitrocellulose membranes in parallel in twofold
serial dilutions, starting from 108 CFU/dot. The membranes
were dried in air, blocked with TBST-casein (Tris-buffered saline [10
mM Tris-HCl, pH 7.4, 150 mM NaCl] plus Tween 20 to 0.05% plus casein
to 0.5%), and incubated with antibodies. A monoclonal antibody (MAb)
against M13 phage coat protein pVIII conjugated with horseradish
peroxidase (HRP) (Amersham Pharmacia Biotech, Piscataway, N.J.), MAbs
against polyhistidine and the c-Myc epitope (clones HIS-1 and 9E10,
respectively, Sigma, St. Louis, Mo.), and the MAb 1D6.14, developed in
our laboratory (6) and recognizing only the trimeric form
of the knob, were used. For unconjugated antibodies, the membranes were
additionally treated with goat anti-mouse immunoglobulin G (IgG)-HRP
conjugate (DAKO, Carpinteria, Calif.). The color reaction was developed
by incubation of the membranes with Sigma Fast diaminobenzidine (Sigma).
The trimer formation of the knob on the phage surface was demonstrated
by immunoblotting knob-displaying phage. Phage preparations
were
diluted with 2× sodium dodecyl sulfate sample buffer (Bio-Rad)
and
divided into two separate tubes, each containing 10
12
phage. One tube from each pair was heated at 96°C for 5 min,
and the
other was left unheated. Phage samples were separated
on 4 to 15%
gradient polyacrylamide gel (PAAG) followed by electrotransfer
onto
polyvinylidene difluoride (PVDF) membranes. After being blocked
with
TBST-casein, the membranes were treated with antibodies followed
by
treatment with goat anti-mouse IgG-HRP conjugate. The color
reaction
was developed by incubation of the membranes with Sigma
Fast
diaminobenzidine.
The functionality of the phage-displayed knobs and the solvent
accessibility of knob-displayed ligands were examined by interaction
in
enzyme-linked immunosorbent assay (ELISA) with recombinant
soluble
human CAR (shCAR) (
5). The shCAR was adsorbed overnight
at
4°C in wells of a 96-well MaxiSorp immunoplate (Nalge Nunc
International, Roskilde, Denmark) at 200 ng/well in 0.1 M bicarbonate
buffer, pH 9.1. After the plates were washed with TBST and blocked
with
TBST-casein, phage were applied in serial dilutions in TBST-casein
and
incubated with shCAR for 1 h at room temperature (RT). Phage-shCAR
interaction was then revealed by treating the wells with anti-M13,
1D6.14 HIS-1, and 9E10 antibodies. The color reaction was developed
by
incubation with Sigma Fast orthophenilenediamine. The color
intensity
was measured at 490 nm on an LE800 plate reader (Bio-Tek
Instruments,
Winooski, Vt.). All binding reactions were done in
triplicate, and mean
values of the three measurements were taken
as
endpoints.
In order to additionally demonstrate the solvent accessibility of a
phage knob-displayed ligand, the ability of polyhistidine
sequences to
bind to metal affinity chromatography matrices, such
as
Ni-nitrilotriacetic acid (NTA) from Qiagen (Valencia, Calif.),
was
exploited. The phages pJuFo, pJuFo.w.t.kn, and pJuFo.kn.6H(C)
(10
9 CFU each) were mixed with 50 µl of Ni-NTA resin in 3 ml of phosphate-buffered
saline (PBS) containing 10 mM imidazole, and
the samples were
incubated for 1 h at RT with end-over-end
rocking, washed five
times with the incubation buffer, and eluted with
200 µl of 0.1
M Tris-glycine, pH 2.5. The eluate was immediately
neutralized
by the addition of 200 µl of 1 M Tris-HCl, pH 7.4, and
used to
infect
E. coli followed by plating the infected
cells onto ampicillin-containing
agar plates as described previously
(
2). The amount of bound
phage was calculated by colony
counting. The binding reactions
were done in triplicates, and the mean
value of the three colony
countings was
used.
The ability of a phage knob-displayed ligand to home to cells
expressing a specific target was examined by immunocytochemistry.
CAR-deficient U118/HisAR (AR stands for artificial receptor) cells
genetically modified to express an anti-six-His single-chain antibody
(scFv) were developed (
7). The U118/HisAR cells and their
parent
glyoma U118 cells (American Type Culture Collection) were grown
to near confluence in the wells of a 24-well tissue culture plate
(Nunc), the growth medium was removed, and the cells were incubated
for
1 h at RT with 10
11 phage displaying either the wt
knob or knob-sixHis in 500 µl
of fresh growth medium. As a control
for AR expression, the cells
were also treated with a MAb, HA-7
(Sigma), against the hemagglutinin
(HA) epitope

the fusion tag on the
AR molecule. The cells were
gently washed three times with the growth
medium and fixed with
10% formaldehyde in PBS for 10 min at RT. Phage
interaction with
the cells was revealed by treatment with an anti-M13
MAb (Amersham
Pharmacia Biotech). The color reaction was developed with
the
DAKO EnVision System according to the manufacturer's
recommendations.
After being stained, the nuclei of the cells were
counterstained
with hematoxylin aqueous formula reagent (Biomeda,
Foster City,
Calif.) according to the manufacturer's
instructions.
 |
RESULTS |
Cloning and phage display of Ad fiber knobs.
The pJuFo system
was used to display the unmodified wt Ad5 fiber knob (amino acids 386 through 581) and knobs incorporating heterologous ligands on the
surfaces of filamentous bacteriophages. The modifications included
incorporation of (i) six consecutive histidine residues at the knob C
terminus [pJuFo.kn.6H(C)], (ii) the c-Myc epitope (EQKLISEEDL) at the
knob C-terminus [pJuFo.kn.myc(C)], and (iii) the c-Myc epitope within
the knob HI loop [pJuFo.kn.myc(HI)]. To clone the c-Myc epitope
sequence into the HI loop without disruption of the native knob amino
acid composition, an intermediate phagemid, pJuFo.kn.2Esp (Fig. 2), was
designed and constructed. The correct gene assembly was confirmed by
DNA sequencing. The recombinant phages pJuFo.w.t.kn, pJuFo.kn.6H(C),
pJuFo.kn.myc(C), and pJuFo.kn.myc(HI) were rescued from E. coli XL1 Blue bacteria transformed with the phagemids by
coinfection with a helper phage. Polyethylene glycol-double-purified phage were examined in a number of assays. We wished to demonstrate that the recombinant bacteriophages displayed recombinant knobs on
their surfaces, that the displayed knobs adopted a native trimeric conformation in the context of the phage particle, that the displayed knobs are functional (they retain the ability to recognize and bind the
primary Ad5 receptor
the CAR), and the ligands displayed in the
context of such functional knobs are exposed and thus are able to
direct knob-displaying phage to a specific target.
Examination of phage-displayed knobs.
The dot modification of
immunoblotting was employed to analyze the presence of the trimeric
knobs at the phage surface and the ligands' accessibility. The
rationale for using this method was based on the ability of
nitrocellulose to adsorb proteins with high efficiency, independent of
protein sorption properties, which could influence direct phage
fixation on plastic. Phages displaying the wt knob, knob.6H(C),
knob.myc(C), and knob.myc(H) were tested. Parent pJuFo phage displaying
no knob were used as a negative control. Aliquots of twofold serial
phage dilutions starting from 2 × 108 CFU/dot were
applied to nitrocellulose membranes, followed by treatment with
anti-bacteriophage, anti-trimeric knob, and anti-ligand (six-His and
c-Myc) antibodies. The results, presented in Fig. 3, demonstrated that the phages were used
in approximately equal amounts (treatment with anti-M13 MAb [Fig.
3A]), that all the phage-displayed knobs interacted with MAb 1D6.14,
recognizing only the trimeric knobs (Fig. 3B), and that both the c-Myc
epitope (treatment with anti-c-Myc MAb [Fig. 3C]) and six-His
(treatment with anti-polyhistidine MAb [Fig. 3D]) phage displayed in
the context of the Ad knob were antibody accessible. It should be noted
here that somewhat abrupt decrease in dot intensity in the last visible
phage dilutions is routinely observed in our other dot assays and seems
to be a comon feature of this kind of analysis.

View larger version (68K):
[in this window]
[in a new window]
|
FIG. 3.
Dot blot analysis of phage-displayed Ad5 knobs.
One-microliter aliquots of the phage were applied to nitrocellulose
membranes in parallel in twofold serial dilutions starting from 2 × 108 CFU/dot. The membranes were dried in air, blocked
with TBST-casein, and incubated with antibodies. When necessary, the
membranes were additionally treated with goat anti-mouse IgG-HRP
conjugate. The color reaction was developed by incubation of the
membranes with Sigma Fast diaminobenzidine. (A) Treatment with mouse
anti-M13 MAb-HRP conjugate; (B) treatment with mouse anti-Ad5 knob MAb
1D6.14; (C) treatment with mouse anti-c-Myc MAb 9E10; (D) treatment
with mouse anti-polyhistidine MAb HIS-1. Lanes: 1, pJuFo phage
displaying no knob; 2, pJuFo phage displaying wt knobs; 3, pJuFo phage
displaying knobs with six His at the C termini; 4, pJuFo phage
displaying knobs with c-Myc at the C termini; 5, pJuFo phage displaying
knobs with c-Myc within the HI loop.
|
|
An additional proof of knob trimer formation on the phage surface was
obtained by phage immunoblotting. Heat-treated and unheated
phage
samples were separated on 4 to 15% PAAG, transferred to
PVDF
membranes, and treated with anti-knob, anti-six-His, and
anti-c-Myc
antibodies. The results, shown in Fig.
4,
demonstrate
the presence of trimeric knobs in all knob-containing
phages.

View larger version (36K):
[in this window]
[in a new window]
|
FIG. 4.
Immunoblot of phages displaying Ad5 knob. Each phage
sample was dissociated in sodium dodecyl sulfate sample buffer and
divided into two tubes. One tube from each pair was heated at 96°C
for 5 min, and the other was left unheated. Phage samples
(1012/lane) were separated on 4 to 15% gradient PAAG
followed by electrotransfer onto PVDF membranes. After being blocked
with TBST-casein, the membranes were treated with antibodies followed
by treatment with goat antimouse IgG-HRP conjugate. The color reaction
was developed by incubation of the membranes with Sigma Fast
diaminobenzidine. (A) Treatment with anti-Ad5 knob MAb 1D6.14; (B)
treatment with anti-polyhistidine MAb HIS-1; (C) treatment with
anti-c-Myc MAb 9E10. Lanes: N, pJuFo phage displaying no knob; W, pJuFo
phage displaying wt knobs 6H, pJuFo phage displaying knobs with six His
at the C termini; MC, pJuFo phage displaying knobs with c-Myc at the C
termini; MHI, pJuFo phage displaying knobs with c-Myc within the HI
loop; b, boiled sample; ub, unboiled sample.
|
|
In order to demonstrate the functionality of the
recombinant-phage-displayed knobs, an ELISA was performed using
purified
recombinant CAR. The shCAR was fixed on plastic, and phage
aliquots
in serial dilutions were applied to the microwells. The same
phage
preparations described for dot analysis above were used.
Phage-shCAR
interaction was developed with anti-M13 MAb, with 1D6.14
anti-knob
MAb, and with anti-c-Myc MAb. Analysis of the results,
presented
in Fig.
5, allowed us to
conclude that all of the phages, except
for the negative control,
recognized and bound the shCAR, which
was revealed by treating the
phage-shCAR complexes with both anti-bacteriophage
(Fig.
5A) and
anti-trimeric knob (Fig.
5B) antibodies. Anti-c-Myc
antibody recognized
the c-Myc epitope in the context of shCAR-bound
phage at both the HI
loop and C-terminal localizations (Fig.
5C).
Thus, these data clearly
show that the introduced ligands are
accessible in the context of
functional trimeric knobs displayed
by the phage.

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 5.
Phage displaying Ad5 knob interaction with CAR in ELISA.
Recombinant shCAR was adsorbed overnight at 4°C in wells of a 96-well
MaxiSorp immunoplate at 200 ng/well in 0.1 M bicarbonate buffer, pH
9.1. After the plates were washed with TBST and blocked with
TBST-casein, phage were applied to the wells in serial dilutions in
TBST-casein, starting from 2 × 1011/well, and
incubated with shCAR for 1 h at RT. Phage-shCAR interaction was
revealed by treating the wells with the set of antibodies described in
the legend to Fig. 3. The color reaction was developed by incubation
with orthophenilenediamine. (A) Treatment with mouse anti-M13 MAb-HRP
conjugate; (B) treatment with mouse anti-Ad5 knob MAb 1D6.14; (C)
treatment with mouse anti-c-Myc MAb 9E10; (D) treatment with mouse
anti-polyhistidine MAb HIS-1. All binding reactions were done in
triplicate, and the mean values of the three measurements were taken as
end points. term., terminus.
|
|
Phage displaying six-His knob bind to Ni-NTA.
We have examined
the potential ability of the six-histidine tag present at the C
terminus of the phage-displayed knob in the construct pJuFo.kn.6H(C) to
interact with the Ni-NTA affinity matrix. The resin was incubated with
109 phage CFU and washed, and the bound phage was eluted by
pH shift. As shown in Fig. 6, in contrast
to the negative control and to the phage displaying the wt knob, the
six histidines have mediated specific phage binding to the Ni-NTA.
Three orders of magnitude binding preference was observed.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 6.
Phage displaying six-His knob bind to Ni-NTA. Phage
(109 CFU) were mixed with 50 µl of Ni-NTA resin in 3 ml
of PBS containing 10 mM imidazole, incubated for 1 h at RT with
end-over-end rocking, washed five times with the incubation buffer, and
eluted with 200 µl of 0.1 M Tris-glycine, pH 2.5. The eluate was
immediately neutralized by the addition of 200 µl of 1 M Tris-HCl, pH
7.4, and used to infect E. coli followed by plating the
infected cells on ampicillin-containing agar plates. The amount of
bound phage was calculated by colony counting. The binding reactions
were done in triplicate, and the mean value of the three colony
countings was used.
|
|
Phage-displayed-knob interaction with U118/HisAR cells.
U118
and U118/HisAR (anti-six-His scFv) cells were treated with pJuFo phage
displaying sixHis at the C terminus of the knob, followed by
development with anti-bacteriophage MAb. The staining results are
presented in Fig. 7. It can be clearly
seen that bacteriophage displaying the Ad5 knob containing the
six-histidine sequence at the C terminus specifically interacted with
the cells expressing an anti-polyhistidine scFv on their surfaces (Fig.
7B). Staining the U118/HisAR cells with an antibody recognizing an HA
epitope present within the AR molecule revealed a similar pattern (Fig. 7D). Phage displaying the wt knob did not react with either U188 or
U118/HisAR cells (not shown).

View larger version (143K):
[in this window]
[in a new window]
|
FIG. 7.
Phage-displayed knob interaction with U118/HisAR cells.
CAR-deficient U118/HisAR cells and their parent U118 cells were grown
to near confluence in the wells of a 24-well tissue culture plate; the
growth medium was removed, and the cells were incubated for 1 h at
RT with 1011 phage displaying six-His knobs in 500 µl of
fresh growth medium. As a control, the cells were also treated with MAb
HA-7 against the HA epitope. The cells were gently washed three times
with the growth medium and fixed with 10% formaldehyde in PBS for 10 min at RT. Phage interaction with the cells was revealed by treatment
with an anti-M13 MAb. The color reaction was developed with the DAKO
EnVision system, which gives bright red staining. The nuclei were
counterstained with hematoxylin aqueous formula. (A) Staining of U118
cells with pJuFo.kn.6H(C); (B) staining of U118/HisAR cells
with pJuFo.kn.6H(C); (C) staining of U118 cells with MAb HA-7; (D)
staining of U118/HisAR cells with MAb HA-7.
|
|
Thus, we have demonstrated that the Ad5 fiber knob could be phage
displayed in an active, functional form. In addition, ligands
incorporated in the phage-displayed knob are accessible and retain
their fidelity: they are able to direct the bacteriophage particle
to
cells expressing a target
molecule.
 |
DISCUSSION |
If Ad vectors are to achieve their full potential as gene delivery
agents for the treatment of human disease, they must be capable of
specific target cell transduction. Both conjugate-based and genetic
approaches have been tried to improve the specificity of Ad
infectivity, with each achieving some measure of success (3). However, at this time there is still a critical lack
of a vector which has the degree of targeting fidelity required for many clinical applications. Development of genetically modified vectors
is attractive because it allows gene therapy with a single integral
agent, a modified virus, thus eliminating the potential complication of
the two-component conjugate approach. The development of such a vector
is, however, limited by the structural constraints of modifying Ad
vectors. In the present report, we present a novel approach for the
definition of targeting ligands which assures a priori structural
compatibility and targeting fidelity. This approach thus has the
potential to substantially improve the development of targeted Ad vectors.
Phage display is a powerful tool to identify ligands that specifically
recognize and bind a target of interest (16). By screening
vast libraries of ligands, a specific ligand that binds to a majority
of targets can be identified. Phage display has already been shown to
allow the definition of ligands which have demonstrated subsequent
utility for Ad-mediated gene delivery (14, 23). We
attempted to demonstrate that the power of the high-throughput phage
display approach could be combined with selecting the target-specific
ligands in the context of an Ad5 knob. In this pilot study, we
displayed the Ad5 knob on the surfaces of filamentous bacteriophages
and demonstrated that ligands displayed in the context of
phage-displayed knobs are able to recognize their targets.
We have demonstrated that the phage-displayed knobs were trimeric, as
shown by the positive interaction of the knob-displaying phages with a
MAb recognizing only the trimeric knob conformation (Fig. 3 to 5). In
addition, the trimer formation was demonstrated by direct phage
immunoblotting (Fig. 4). The knobs were shown to remain functionally
active: they all retained the ability to recognize and bind the Ad5
receptor CAR (Fig. 5). It is important to note that the observed
knob-shCAR interaction was developed with treatment by an
anti-bacteriophage antibody. These results strongly suggest that the
knobs are physically connected to the phage body and minimizes the
likelihood that such an interaction may be mediated by loose knobs
present in the prokaryotic phage preparations. The current model of
Ad-CAR interaction is that the fiber can only bind the CAR as a trimer
(17). In this study, the positive knob phage-shCAR binding
results added to our confidence that the phage-displayed knobs are trimeric.
An important issue in our investigation was whether a ligand situated
in the context of the phage-displayed Ad5 knob retains its
target-binding capacity. As was shown in our experiments with selective
binding of six-His-tagged phage-displayed knobs to Ni-NTA, we observed
at least 3.5 orders of magnitude preferential binding in comparison to
phage displaying the wt knob and to the negative control phage (Fig.
6).
Finally, we have demonstrated the ability of a phage knob-displayed
ligand to interact with its specific receptor presented on living
cells. The immunocytostaining results presented in Fig. 7 clearly show
that the phage-cell binding pattern was similar to that of a MAb to the
HA epitope present on the AR molecule.
Taken together, the data support the concept that phage display of the
Ad5 knob provides a useful tool for investigation of ligand-knob
fidelity and structural compatibility. Ligand candidates can be tested
in this phage display system prior to the generation of an actual
modified Ad. Moreover, screening libraries of random peptides using the
phage display system described here will allow the selection of ligands
that are knob (i.e., Ad) compatible and that retain fidelity. One
important issue is whether the ligands identified using our knob phage
display system will retain fidelity in the context of modified Ad. The
ligand-screening procedure is twofold: screening for specificity
followed by screening for compatibility (trimer formation). Since the
fiber-trimerizing forces on the virion are much stronger than those on
our artificial system (there are several shaft repeats stabilizing the
fiber trimer compared with just one shaft repeat in our knob-pJuFo
system), even weak trimers on phage should reflect much more stable
trimers formed on the virion.
In the present report, we have established the feasibility of
displaying peptide ligands in the context of the Ad5 knob on the
surfaces of bacteriophages. This will enable the generation of knob
peptide libraries suitable for screening against both purified proteins
and cells. For maximal utility, however, especially in the context of
library screening against cells (which may express various amounts of
CAR), the knob displayed on the phage will need to be mutated to ablate
its natural recognition of CAR. This can easily be achieved by simple
point mutation (17) without disturbing the region into
which the peptide libraries are inserted. In this way, the
applicability of the approach may be greatly improved, since ligand
selection will not be compromised by CAR recognition.
 |
ACKNOWLEDGMENTS |
This work has been supported by Department of Defense grants
P50CA89019 and P50CA83591, NIH grants CA74242 and CA68245 and NCI
contract N01-CO-97110.
We thank Victor Krasnykh and Joanne Douglas for providing necessary
material used in the study. We also thank Paul Reynolds for fruitful
discussion of the manuscript.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: WTI 620, 1824 Sixth Ave. South, Birmingham, AL 35294. Phone: (205) 934-9516. Fax:
(205) 975-7476. E-mail: david.curiel{at}ccc.uab.edu.
 |
REFERENCES |
| 1.
|
Chroboczek, J., and B. Jacrot.
1987.
The sequence of adenovirus fiber: similarities and differences between serotypes 2 and 5.
Virology
161:549-554[CrossRef][Medline].
|
| 2.
|
Crameri, R.,
S. Hemmann, and K. Blaser.
1996.
PJuFo: a phagemid for display of cDNA libraries on phage surface suitable for selective isolation of clones expressing allergens.
Adv. Exp. Med. Biol.
409:103-110[Medline].
|
| 3.
|
Curiel, D. T.
1999.
Strategies to adapt adenoviral vectors for targeted delivery.
Ann. N. Y. Acad. Sci.
886:158-171[CrossRef][Medline].
|
| 4.
|
Dmitriev, I.,
V. Krasnykh,
C. R. Miller,
M. Wang,
E. Kashentseva,
G. Mikheeva,
N. Belousova, and D. T. Curiel.
1998.
An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism.
J. Virol.
72:9706-9713[Abstract/Free Full Text].
|
| 5.
|
Dmitriev, I.,
E. Kashentseva,
B. E. Rogers,
V. Krasnykh, and D. T. Curiel.
2000.
Ectodomain of coxsackievirus and adenovirus receptor genetically fused to epidermal growth factor mediates adenovirus targeting to epidermal growth factor receptor-positive cells.
J. Virol.
74:6875-6884[Abstract/Free Full Text].
|
| 6.
|
Douglas, J. T.,
B. E. Rogers,
M. E. Rosenfeld,
S. I. Michael,
M. Feng, and D. T. Curiel.
1996.
Targeted gene delivery by tropism-modified adenoviral vectors.
Nat. Biotechnol.
14:1574-1578[CrossRef][Medline].
|
| 7.
|
Douglas, J. T.,
C. R. Miller,
M. Kim,
I. Dmitriev,
G. Mikheeva,
V. Krasnykh, and D. T. Curiel.
1999.
A system for the propagation of adenoviral vectors with genetically modified receptor specificities.
Nat. Biotechnol.
17:470-475[CrossRef][Medline].
|
| 8.
|
Haisma, H. J.,
J. Grill,
D. T. Curiel,
S. Hoogeland,
V. W. van Beusechem,
H. M. Pinedo, and W. R. Gerritsen.
2000.
Targeting of adenoviral vectors through a bispecific single-chain antibody.
Cancer Gene Ther.
7:901-904[CrossRef][Medline].
|
| 9.
|
Hong, S. S.,
A. Galaup,
R. Peytavi,
N. Chazal, and P. Boulanger.
1999.
Enhancement of adenovirus-mediated gene delivery by use of an oligopeptide with dual binding specificity.
Hum. Gene Ther.
10:2577-2586[CrossRef][Medline].
|
| 10.
|
Krasnykh, V. N.,
I. Dmitriev,
G. Mikheeva,
C. R. Miller,
N. Belousova, and D. T. Curiel.
1996.
Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob.
J. Virol.
72:1844-1852[Abstract/Free Full Text].
|
| 11.
|
Krasnykh, V. N.,
G. V. Mikheeva,
J. T. Douglas, and D. T. Curiel.
1996.
Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism.
J. Virol.
70:6839-6846[Abstract/Free Full Text].
|
| 12.
|
Louis, N.,
P. Fender,
A. Barge,
P. Kitts, and J. Chroboczek.
1994.
Cell-binding domain of adenovirus serotype 2 fiber.
J. Virol.
68:4104-4106[Abstract/Free Full Text].
|
| 13.
|
Michael, S. I.,
J. S. Hong,
D. T. Curiel, and J. A. Engler.
1995.
Addition of a short peptide ligand to the adenovirus fiber protein.
Gene Ther.
2:660-668[Medline].
|
| 14.
|
Pasqualini, R.,
E. Koivunen, and E. Ruoslahti.
1997.
Alpha v integrins as receptors for tumor targeting by circulating ligands.
Nat. Biotechnol.
15:542-546[CrossRef][Medline].
|
| 15.
|
Reynolds, P. N.,
K. R. Zinn,
V. D. Gavrilyuk,
I. V. Balyasnikova,
B. E. Rogers,
D. J. Buchsbaum,
M. H. Wang,
D. J. Miletich,
W. E. Grizzle,
J. T. Douglas,
S. M. Danilov, and D. T. Curiel.
2000.
A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivo.
Mol. Ther.
2:562-578[CrossRef][Medline].
|
| 16.
|
Rodi, D. J., and L. Makowski.
1999.
Phage-display technology finding a needle in a vast molecular haystack.
Curr. Opin. Biotechnol.
10:87-93[CrossRef][Medline].
|
| 17.
|
Roelvink, P. W.,
G. M. Lee,
D. A. Einfeld,
I. Kovesdi, and T. J. Wickham.
1999.
Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing Adenoviridae.
Science
286:1568-1571[Abstract/Free Full Text].
|
| 18.
|
Russell, W. C.
2000.
Update on adenovirus and its vectors.
J. Gen. Virol.
81:2573-2604[Free Full Text].
|
| 19.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 20.
|
Smith, G. P.
1985.
Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface.
Science
14:1315-1317.
|
| 21.
|
Trepel, M.,
M. Grifman,
M. D. Weitzman, and R. Pasqualini.
2000.
Molecular adaptors for vascular-targeted adenoviral gene delivery.
Hum. Gene Ther.
11:1971-1981[CrossRef][Medline].
|
| 22.
|
Wickham, T. J.,
P. W. Roelvink,
D. E. Brough, and I. Kovesdi.
1996.
Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types.
Nat. Biotechnol.
14:1570-1573[CrossRef][Medline].
|
| 23.
|
Xia, H.,
B. Anderson,
Q. Mao, and B. L. Davidson.
2000.
Recombinant human adenovirus: targeting to the human transferrin receptor improves gene transfer to brain microcapillary endothelium.
J. Virol.
74:11359-11366[Abstract/Free Full Text].
|
Journal of Virology, August 2001, p. 7107-7113, Vol. 75, No. 15
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.15.7107-7113.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Ghosh, D., Barry, M. A.
(2005). Selection of Muscle-Binding Peptides from Context-Specific Peptide-Presenting Phage Libraries for Adenoviral Vector Targeting. J. Virol.
79: 13667-13672
[Abstract]
[Full Text]
-
Fontana, L., Nuzzo, M., Urbanelli, L., Monaci, P.
(2003). General Strategy for Broadening Adenovirus Tropism. J. Virol.
77: 11094-11104
[Abstract]
[Full Text]